A Study to Evaluate the Safety and Efficacy of Ublituximab in Combination With Umbralisib for Participants Previously Enrolled in Protocol UTX-TGR-304
Clinical trial NCT02656303 · TERMINATED
Trial details
- NCT number
- NCT02656303
- Sponsor
- TG Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-07
- Primary completion
- 2022-05-26
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.